Whole brain irradiation (WBI) is a common treatment for both primary brain tumors and prevention of metastases. Unfortunately, approximately 50% of the 200,000 cancer patients who receive WBI each year develop progressive cognitive deficits > 6 months after treatment, due to normal tissue damage. The cellular and molecular mechanisms underlying WBI-induced brain injury remain unknown. There are currently no successful treatments or preventative measures against late delayed effects. Blockade of the renin-angiotensin system (RAS) is an attractive therapeutic target, since RAS blockers are well-established in the clinic and were shown previously to ameliorate radiation-induced lung and kidney injury. This proposal will test the efficacy of the angiotensin II type 1 receptor (AT1R) blocker L-158,809 against WBI-induced brain injury. It will determine the effects of AT1R blockade on: i) the WBI-induced inflammatory response, as measured by the expression of pro-inflammatory cytokines, via ELISAs, and indices of microglial proliferation and activation, via IHC, and ii) radiation-induced changes in neurogenesis and the association of precursor cells and the microvasculature in the dentate gyrus, via IHC & stereology. The hypothesis is that WBI-induced inflammatory response is mediated by the brain RAS and, therefore, that RAS blockade will reduce radiation-induced inflammation and injury. The above aims will test the effects of a widely prescribed and well-tolerated drug class, successful results in this animal model can be readily translated to clinical trials that could improve significantly the quality of life for long-term cancer survivors treated with WBI. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
1F31NS056678-01A1
Application #
7275539
Study Section
Special Emphasis Panel (ZRG1-F01-N (20))
Program Officer
Fountain, Jane W
Project Start
2007-04-15
Project End
2009-04-14
Budget Start
2007-04-15
Budget End
2008-04-14
Support Year
1
Fiscal Year
2007
Total Cost
$35,572
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Conner, Kelly R; Forbes, M Elizabeth; Lee, Won Hee et al. (2011) AT1 receptor antagonism does not influence early radiation-induced changes in microglial activation or neurogenesis in the normal rat brain. Radiat Res 176:71-83
Conner, Kelly R; Payne, Valerie S; Forbes, M Elizabeth et al. (2010) Effects of the AT1 receptor antagonist L-158,809 on microglia and neurogenesis after fractionated whole-brain irradiation. Radiat Res 173:49-61